Font size:

Heterotaxy Connection

Cycle 3

Heterotaxy is a congenital condition that disrupts the normal left-right asymmetry of the body. This can result in any of the internal organs being misplaced, malformed, multiplied, or missing entirely. This disruption in asymmetry ensures that no two cases of heterotaxy are exactly alike. The cause of heterotaxy is not fully understood; some genetic links are being explored, but not all cases have been found to have a genetic cause, so research is still needed. Individuals with heterotaxy require lifelong multidisciplinary care and medical monitoring.

Last updated 04/30/2026

Clinical

Disease Class
Abdominal surgical diseases
Cardiac malformations
Ciliopathies
Developmental anomalies during embryogenesis
Gastroenterological diseases
Immunological diseases
Renal diseases
Respiratory diseases
Surgical thoracic diseases
Body Systems
Cardiovascular / Circulatory
Digestive
Renal / Urinary / Excretory
Respiratory
Organs
Arteries
Bile ducts
Heart
Intestines
Kidneys
Liver
Lungs
Pancreas
Spleen
Stomach
Veins
Known Genetic Link
Yes, one or more genes directly cause the condition
Causative Genes
ACVR2B
CFAP53
CFC1
CITED2
CRELD1
DNAH11
FOXH1
GATA4
GDF1
LEFTY-1
LEFTY-2
MMP21
NAT10
NKX2.5
NODAL
NU205
NUP188
NUP210
SHROOM3
ZIC3
Contributory Genes
None specified / unknown
Type of Inheritance
Not specified / unknown
Newborn Screening
No
Disease Mechanism(s)
Unknown
Age of Onset
Prebirth
Average Age at Diagnosis
Pre-Birth
Life Expectancy
Adolescence (12-17)
Adulthood (age 18-64)
Early childhood (age 1+-5)
Infancy (age 0-1)
Middle childhood (6-11)
Affected Sex(es)
Female
Intersex
Male
National Prevalence
1001-10000
Global Prevalence
1001-10000
National Incidence
10000+
Global Incidence
10000+
Populations and/or ancestry with higher prevalence
China has a higher prevalence
Symptoms / Phenotypes
abdominal swelling
hypoxemia
jaundice
respiratory insufficiency / respiratory failure
vomiting / nausea
Biomarkers
None
Existing Therapies
Other
· palliative surgeries
Therapies in Development
Not applicable
Therapeutic Development Stages
Not applicable/No treatments available
Therapeutic Development Role
None

Organizational & Research

Cell Lines
None
Cell Lines, Institution
None
Cell Lines, share
N/A
Disease Model
None
Disease Model, share
N/A
Organizational Challenges
Not applicable
Clinical Trial Role
Not involved
Biobank, Institution
None
Center of Excellence, Institution
Unspecified
Center of Excellence, Involvement
Consulted
Designed
Registry
Yes, we have collaborated on a registry
Data Collected, Registry
Electronic health records/electronic medical records
Data Entered by, Registry
Clinicians
Platform, Registry
Not specified
Natural History Study
Yes, we have a natural history study that we created
Data Collected, Natural History Study
Imaging data
Patient-reported outcomes
Retrospective data
Platform, Natural History Study
Citizen Health
FDA Patient Listening Session
No
FDA Patient-Focused Drug Development (PFDD) Program
No
ICD Codes
No, we do not have any ICD codes
Diagnostic Guidelines
In the process of creating formal diagnostic guidelines for publication in a peer-reviewed journal
Science Advisory Board Policies
No policies
Research Network Policies
Does not have a CRN
Patient Priority Survey
Yes
Patient Priority Survey, share
Yes, will share
Research Roadmap
We don't have a Research Roadmap
International Chapters
None
International Partners
None
Other International Research Initiatives
None